Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-24-002324

Chief Medical Officer bought 280,000 shares at $0.50 ($139,888)

From the SEC's structured data for this filing

Trades in this filing

Puhlmann Markus · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-01-24 Purchase : show line 1 in the form +280,000 $0.50 $139,888 1,375,425 D
Open-market purchases · 280,000 sh · avg $0.50 · $139,888
Loading xslF345X05/rdgdoc.xml…